Phase 2 Study Of Clofarabine With High Dose Cytarabine And G-CSF Priming In Adult Patients Less Than Age 65 With Newly Diagnosed Acute Myeloid Leukemia Or Advanced Myelodysplastic Syndrome and/or Advanced Myeloproliferative Neoplasm.
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Clofarabine (Primary) ; Cytarabine (Primary) ; Filgrastim (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes; Myeloproliferative disorders
- Focus Therapeutic Use
- 18 Sep 2017 Status changed from active, no longer recruiting to completed.
- 19 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 Mar 2012 Additional lead trial investigator (Anthony Stein) identified as reported by ClinicalTrials.gov.